Maine Revised Statutes Title 22 Sec. 8733 – Confidentiality
Current as of: 2023 | Check for updates
|
Other versions
Information provided to the organization as required by this subchapter by a manufacturer, wholesale drug distributor or pharmacy benefits manager is confidential and not a public record under Title 1, chapter 13, except that the organization may share information: [PL 2019, c. 470, §8 (NEW).]
1. Bureau of Insurance. With the Department of Professional and Financial Regulation, Bureau of Insurance, to the extent necessary for the bureau to enforce the provisions of Title 24?A, as long as any information shared is kept confidential;
[PL 2021, c. 305, §7 (AMD).]
Terms Used In Maine Revised Statutes Title 22 Sec. 8733
- Contract: A legal written agreement that becomes binding when signed.
- Department: means the Department of Health and Human Services. See Maine Revised Statutes Title 22 Sec. 1-A
- Manufacturer: means an entity that manufactures or repackages, and sets the wholesale acquisition cost for, prescription drugs that are distributed in the State. See Maine Revised Statutes Title 22 Sec. 8731
- Organization: means the Maine Health Data Organization established under this chapter. See Maine Revised Statutes Title 22 Sec. 8702
- Prescription drug: means a drug, as defined in 21 United States Code § 321(g) or a biological product as defined in 42 United States Code § 262(i)(1) that:
2. Aggregate. In the aggregate, as long as it is not released in a manner that allows the determination of individual prescription drug pricing contract terms covering a manufacturer, wholesale drug distributor or pharmacy benefits manager; and
[PL 2021, c. 305, §7 (AMD).]
3. Publicly available. That is available, for purchase or otherwise, to the public.
[PL 2021, c. 305, §7 (NEW).]
SECTION HISTORY
PL 2019, c. 470, §8 (NEW). PL 2021, c. 305, §7 (AMD).